Cargando…
Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo
Inactivation of tumor suppressor gene p16/INK4A and oncogenic activation of KRAS occur in almost all pancreatic cancers. To better understand the roles of p16 in pancreatic tumorigenesis, we created a conditional p16 knockout mouse line (p16(flox/flox)), in which p16 is specifically disrupted in a t...
Autores principales: | Qiu, Wanglong, Sahin, Fikret, Iacobuzio-Donahue, Christine A., Garcia-Carracedo, Dario, Wang, Wendy M., Kuo, Chia-Yu, Chen, Doris, Arking, Dan E., Lowy, Andrew M., Hruban, Ralph H., Remotti, Helen E., Su, Gloria H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259996/ https://www.ncbi.nlm.nih.gov/pubmed/22113502 |
Ejemplares similares
-
KRAS mutation analysis in ductal carcinoma of the pancreas; prognostic implications in elderly patients
por: Oldani, Alberto, et al.
Publicado: (2013) -
Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma
por: Rodić, Nemanja, et al.
Publicado: (2015) -
Acinar Cell Carcinoma of the Pancreas: Clinical and Cytomorphologic Characteristics
por: Toll, Adam D., et al.
Publicado: (2013) -
Smad4 Loss Synergizes with TGFα Overexpression in Promoting Pancreatic Metaplasia, PanIN Development, and Fibrosis
por: Garcia-Carracedo, Dario, et al.
Publicado: (2015) -
Diagnosis and Management of Cystic Lesions of the Pancreas
por: Jani, Niraj, et al.
Publicado: (2011)